Reinvestment Rate × ROIC: Damodaran's True Growth Formula
Earnings growth equals reinvestment rate times ROIC — Aswath Damodaran's formula explains why Costco compounds and why high-growth stories often stall.

Key Takeaways
- Earnings growth = Reinvestment Rate × ROIC — every other growth number is downstream of this one
- Reinvestment rate = (capex + R&D + ΔWorking Capital − D&A) ÷ after-tax operating income
- A roughly 50% reinvestment rate at a 20% ROIC produces approximately 10% intrinsic earnings growth — the rule-of-10
- Companies that grow faster than the formula predicts are either (a) acquiring growth or (b) under-investing in maintenance
- The formula breaks for asset-light platforms (Visa (V), Mastercard (MA)) and for companies in a deleveraging phase
Most investors treat earnings growth as a single number on a sell-side spreadsheet. Aswath Damodaran's reinvestment rate × ROIC formula reveals the only two levers that actually create it — and the math explains why Costco (COST) compounds while many higher-growth peers stall.
What does the formula actually say?
The answer is a deceptively simple equation.
Expected earnings growth = Reinvestment Rate × Return on Invested Capital
NYU finance professor Aswath Damodaran has spent roughly 25 years arguing that this is the only growth equation that matters. Every other growth number — analyst forecasts, management guidance, PEG ratios — is downstream of these two inputs. Get those right and you get growth right.
The intuition: a company can only grow by reinvesting cash flow into new productive assets, and the productivity of those new assets is measured by ROIC. If a business reinvests roughly 50% of operating income at a 20% ROIC, it grows earnings at approximately 10% (0.50 × 0.20). It really is that mechanical.
The trick is computing both terms honestly. Most investors get the reinvestment rate wrong because they ignore working capital and R&D.
How do you calculate the reinvestment rate?
The honest formula is:
Reinvestment Rate = (Capex + R&D + ΔWorking Capital − D&A) ÷ After-tax Operating Income
Three components matter, and most people miss two of them.
Capex minus D&A is the easy one. Anything above maintenance depreciation is true growth investment. If a company spends approximately $10 billion of capex against roughly $6 billion of D&A, the net growth capex is about $4 billion.
R&D belongs in reinvestment, not operating expenses, for any technology or pharma business. The accounting rules force Alphabet (GOOGL), Microsoft (MSFT), and Eli Lilly (LLY) to expense R&D immediately even though the economic life of that spend stretches 5-15 years. Damodaran's adjustment capitalizes R&D and amortizes it — which roughly doubles the reinvestment rate for software businesses.
Working capital changes matter when growth is inventory- or receivable-intensive. Retailers like Costco (COST) and Walmart (WMT) run negative working capital (suppliers fund the business), so growth actually releases cash. For most growing manufacturers, the opposite is true: every dollar of revenue growth ties up approximately 15-25 cents of working capital.
How do you calculate ROIC correctly?
ROIC = NOPAT ÷ (Equity + Total Debt − Cash)
NOPAT is net operating profit after tax: operating income times (1 minus effective tax rate). Invested capital is equity plus interest-bearing debt minus excess cash.
Two clean-ups make a real difference.
First, capitalize R&D the same way you did for reinvestment. Otherwise software businesses look artificially capital-light and their ROIC is overstated. A company like Adobe (ADBE) with roughly $5 billion of annual R&D shows materially different ROIC numbers before and after capitalization.
Second, subtract excess cash. Apple (AAPL) has historically carried roughly $50-150 billion of excess cash that has nothing to do with operations. Including it in invested capital understates the true ROIC of the actual operating business.
The clean ROIC number for high-quality compounders typically lands somewhere between 20% and 40% — anything below approximately 12% is below most reasonable cost-of-capital estimates and is destroying value through reinvestment.
Who actually compounds at what rate?
The answer becomes obvious when you put a handful of real businesses through the formula side by side.
| Company | Reinvest rate (approx) | ROIC (approx) | Implied growth | Reality check |
|---|---|---|---|---|
| Costco | 35% | 21% | 7% | Tracks reported earnings growth |
| Microsoft | 65% | 28% | 18% | Mostly tracks; some buyback drag |
| Visa | 15% | 30%+ | 5% | Network effect — reinvestment optional |
| Eli Lilly | 75% | 22% | 17% | GLP-1 boom reinvested aggressively |
| Walmart | 35% | 15% | 5% | Tight match to actual EPS growth |
That table tells you two stories.
Story 1: Companies with high reinvestment rates AND high ROIC (e.g., MSFT, LLY) compound earnings fast — because both inputs to the formula are high.
Story 2: Asset-light platforms (V, MA) have absurd ROICs but cannot reinvest much without destroying their model — so growth is naturally capped by where they can deploy capital. That is why they tend to return roughly 80-100% of free cash flow to shareholders via buybacks and dividends.
Common mistakes investors make
Mistake 1 — Using analyst EPS growth as the input. Analysts triangulate from management guidance, which is biased upward. The reinvestment rate × ROIC formula is a bottoms-up sanity check on analyst numbers. When the formula predicts 8% and consensus is 18%, somebody is lying — and it is usually not the formula.
Mistake 2 — Ignoring buybacks vs net new investment. A company can post 15% EPS growth on roughly 5% net income growth via buybacks. That is not the same thing as 15% earnings growth from reinvestment. The formula calculates operating earnings growth, not EPS growth. The buyback adjustment is separate.
Mistake 3 — Treating M&A as organic. A company that grows earnings 12% via three acquisitions is not compounding at 12% organically. Strip out acquired earnings and look at the underlying reinvestment math. Real organic growth is typically materially lower than reported growth at acquisitive companies.
Mistake 4 — Confusing maintenance capex with growth capex. Net capex above D&A is growth investment. Net capex equal to D&A is maintenance — by definition, it produces no growth. A company that posts 10% revenue growth while running capex equal to D&A is either (a) levering working capital or (b) running ahead of its sustainable rate.
Pro tips for using this framework
Use it as a multi-year average. Single-year numbers swing on cycle and accounting noise. A 5-year rolling average of reinvestment rate and ROIC is the cleanest input.
Compare to history. When a company's current reinvestment rate is materially different from its 10-year average, ask why. Either the opportunity set expanded (Nvidia (NVDA) post-2023, Eli Lilly (LLY) post-GLP-1) or contracted (legacy energy majors, industrial commodity businesses in late cycle).
Reverse-engineer the implied growth. If a stock trades at 25x earnings, the market is pricing in roughly 12-15% earnings growth. Plug your reinvestment rate × ROIC estimate into the formula. If the math produces 6%, the multiple is reaching. If it produces 18%, there is real margin of safety.
For a related framework on how cash flow turns into compounding, our fundamental analysis index has the matching guides on owner earnings and free cash flow. For how the legendary investors think about quality compounders, see our investment strategies guide.
When NOT to use this formula
The framework breaks in three specific situations.
Situation 1 — Asset-light platforms. V and MA have ROICs north of approximately 30% but reinvestment rates below 20% because their network is largely built. The formula understates their intrinsic growth because the embedded operating leverage is not captured in invested capital. For these names, focus on volume growth × take rate × operating leverage instead.
Situation 2 — Deleveraging stories. When a company is paying down debt, free cash flow appears to go nowhere even though earnings power is improving. Reinvestment rate × ROIC underestimates near-term growth because debt paydown is not in either term.
Situation 3 — Turnarounds. A company crawling out of restructuring may have a depressed ROIC that does not reflect normalized economics. The math says no growth; reality may say a doubling once normalized margins return.
In all three cases, the formula is still useful — but as a sanity check on the terminal growth assumption, not the next-3-years number.
Ready to analyze these stocks yourself? Search any ticker on MainRatios to see valuations from 6 legendary investors - free.
See what Benjamin Graham would pay
Graham formula intrinsic value on every ticker. Know the price before you buy.
View Graham's valuationsFrequently Asked Questions
Aswath Damodaran at NYU Stern popularized the framework in academic finance and his valuation textbooks starting in the late 1990s. The intuition predates him (it is mathematically equivalent to the dividend discount model's growth term), but he made it the standard valuation input.


